v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows From Operating Activities:    
Net (loss) income $ (1,430,668) $ 9,194,630
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 67,400 69,942
Stock based compensation 277,654 754,361
Equity compensation expense 671
Non-cash interest expense 90,450
Amortization of debt discount 30,110
Change in fair value of derivative liabilities (561,350) (12,417,450)
Changes in operating assets and liabilities:    
Accounts receivable (10,514)
Prepaid expenses 103,439 (302,034)
Deferred offering costs (460,915)
Other current assets (371,163) (607,376)
Accounts payable and accrued expenses 2,043,286 867,249
Income taxes payable (6,369)
Excise taxes 95,858 13,648
Due to related party 75,000
Net Cash Used In Operating Activities (141,863) (2,342,278)
Cash Flows From Investing Activities:    
Capitalized patent costs (23,975) (40,156)
Net Cash Used In Investing Activities (23,975) (40,156)
Cash Flows From Financing Activities:    
Repayment of short-term notes (42,671)
Proceeds from issuance of common stock from exercise of warrants 241,546
Net Cash Provided By Financing Activities 198,875
Net change in cash (165,838) (2,183,559)
Cash at beginning of period 204,725 3,353,732
Cash at end of period 38,887 1,170,173
Supplemental disclosure    
Cash paid for interest expense 7,329
Cash paid for federal income taxes 6,369
Supplemental disclosure of non-cash financing activities:    
Issuance of Common Stock upon the closing of the Merger 414
FPA discount accretion 78,247
Debt discount recognized on note payable 70,000
Convertible notes converted to common shares 527,500
Capitalized interest to principal balance of short-term note payable 90,450
Reverse stock split — reclassification from common stock to additional paid-in capital 13,311
Shares issued upon settlement of warrants $ 24